Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA sweet or unusual taste in the mouth is something a number of people notice in the early weeks of semaglutide treatment. It tends to appear after starting Wegovy or increasing the dose, often alongside other mild changes in how food and drink taste. It is not a listed side effect in the Wegovy SmPC, but it is a real and documented experience — and there are a few straightforward explanations for why it happens. These medicines are prescription-only, meaning a prescriber assesses your full medical picture before treatment begins and remains your point of contact if anything unexpected comes up.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating GLP-1 receptors, proteins found not just in the gut but in several areas of the brain involved in appetite, reward and sensory processing. When those receptors are activated, signals related to fullness and food desirability shift. Part of that shift can affect how the mouth perceives flavour. GLP-1 receptors are present in the taste-bud circuitry, and their activation appears to alter the threshold at which certain tastes register, particularly sweetness and fat.
Separately, semaglutide significantly slows gastric emptying, the rate at which food leaves the stomach. This can cause a mild but persistent reflux of stomach contents, including sugars and partially digested food, into the lower oesophagus. That reflux doesn't always cause heartburn; sometimes the only sign is a faint sweet or acidic note at the back of the throat. The full mechanism of semaglutide is explained in more detail elsewhere, but both of these pathways help explain why taste changes happen without appearing on the formal side-effect list.
Understanding the cause matters because it tells you what to expect. This is not a sign that something is wrong with your medication or your body's response to it. It is a downstream effect of the same biology that makes the treatment work.
A question our prescribers hear most weeks is whether the sweet taste is a sign the dose needs adjusting. In most cases, it isn't. The pattern is fairly consistent: the taste appears or intensifies shortly after a dose change, peaks around day two or three, then gradually fades as the body adjusts. Some people describe it as metallic-sweet; others say food itself tastes sweeter than expected or that plain water has an odd quality, and those who find the flavour quality shifts distinctly may find it useful to read about the bad taste in mouth some people experience on Wegovy. The range of taste changes people notice on Wegovy is broader than the sweet note alone.
What is worth watching is a different picture: taste changes that worsen rather than settle, or that come with severe, persistent stomach pain radiating toward the back. In January 2026, the MHRA issued a Drug Safety Update on GLP-1 medicines highlighting acute pancreatitis as a known infrequent but serious risk; severe stomach pain is the primary symptom to act on urgently. Taste changes without pain are a very different story, but if both appear together, get medical help promptly rather than waiting for your next review.
Nausea is the most common GI side effect on semaglutide; a sweet taste in the mouth sometimes accompanies it as part of the same gastric-slowing picture. If nausea is causing you to eat very little, staying hydrated becomes especially important.
There is no single fix, but several straightforward adjustments tend to reduce the intensity of taste changes. Eating smaller, blander meals reduces the amount of food sitting in a slowed stomach. Staying well-hydrated keeps the mouth from drying out, which otherwise concentrates taste sensations. Avoiding very sweet or very fatty foods (the flavours most affected by GLP-1 receptor changes) can reduce the contrast. Chewing sugar-free gum after meals helps some people manage a lingering sweet note.
The timing of your weekly injection can also matter. Some people find that scheduling the injection toward the end of the week (so the strongest effects fall over days when eating is less socially important) makes the early adjustment period easier to manage. Your prescriber sets the clinical plan; these practical points sit alongside it, not instead of it.
If you are weighing up whether these early-adjustment effects are worth pressing through, it helps to read about what stopping Wegovy abruptly involves before making any changes, stopping is a decision for you and your prescriber together, not something to do unilaterally in a difficult week. If you want a broader look at how the cost of treatment sits alongside these considerations, the UK Wegovy price comparison sets out the context plainly.
Most taste changes on semaglutide resolve within two to four weeks of a dose change and do not need a formal clinical response. You do not need to contact your prescriber urgently for a mild sweet taste that is fading. But if the taste is persistent, getting worse, or affecting your ability to eat or drink adequately, flag it. The same applies if it is accompanied by any digestive symptom that concerns you, your prescriber can review whether the dose timeline needs adjusting.
Changes to taste can occasionally reflect something unrelated to semaglutide, including dental issues, dry mouth from other medicines, or changes in blood glucose in people with diabetes or prediabetes. A prescriber who knows your full history is best placed to distinguish between these. The NHS provides patient-level information on semaglutide side effects and how to manage them, and it is worth reading the Patient Information Leaflet that came with your pen. If something about your experience feels off, speak up, the people at the clinical team at nume are there to help between doses, not just at the start of treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.